Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease
- 31 July 2004
- journal article
- research article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 94 (1), 197-203
- https://doi.org/10.1016/j.ygyno.2004.04.004
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Evaluation of complete surgical staging with pelvic and para-aortic lymphadenectomy and paclitaxel plus carboplatin chemotherapy for improvement of survival in stage i ovarian clear cell carcinomaGynecologic Oncology, 2003
- Allelotype Analysis of Common Epithelial Ovarian Cancers with Special Reference to Comparison between Clear Cell Adenocarcinoma with Other Histological TypesJapanese Journal of Cancer Research, 2002
- Clinical characteristics of clear cell carcinoma of the ovaryCancer, 2000
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerThe New England Journal of Medicine, 1996
- Clear Cell Epithelial Ovarian Cancer (Mesonephroid): Bad Prognosis Only in Early StagesGynecologic Oncology, 1993
- Uterine papillary serous carcinoma: A study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinomaGynecologic Oncology, 1992
- Uterine Serous Carcinoma A Morphologically Diverse Neoplasm With Unifying Clinicopathologic FeaturesThe American Journal of Surgical Pathology, 1992
- Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience.Journal of Clinical Oncology, 1991
- Endometrioid and Clear Cell Carcinoma of the OvaryInternational Journal of Gynecological Pathology, 1989
- Clear cell carcinoma of the ovary: A clinicopathologic study with review of the literatureCancer, 1981